CRISPR Therapeutics AG - Common Shares (NQ:CRSP)
Price and Volume
Detailed Quote| Volume | 1,247,756 |
| Open | 52.57 |
| Bid (Size) | 51.55 (300) |
| Ask (Size) | 52.00 (100) |
| Prev. Close | 52.96 |
| Today's Range | 51.49 - 52.84 |
| 52wk Range | 44.12 - 78.48 |
| Shares Outstanding | 78,935,098 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Why CRISPR Therapeutics Stock Rocked the Market Last Month ↗
September 08, 2026
Where Will CRISPR Therapeutics Stock Be in 5 Years? ↗
September 08, 2026
3 Stocks With the Most Upside by the End of 2026 ↗
July 30, 2026
3 Reasons to Buy CRISPR Therapeutics Stock ↗
July 10, 2026
The Best Stocks to Invest $1,000 in Right Now ↗
June 22, 2026
The Best Biotech Stocks to Buy in 2026 ↗
June 17, 2026
Frequently Asked Questions
Is CRISPR Therapeutics AG - Common Shares publicly traded?
Yes, CRISPR Therapeutics AG - Common Shares is publicly traded.
What exchange does CRISPR Therapeutics AG - Common Shares trade on?
CRISPR Therapeutics AG - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for CRISPR Therapeutics AG - Common Shares?
The ticker symbol for CRISPR Therapeutics AG - Common Shares is CRSP on the Nasdaq Stock Market
What is the current price of CRISPR Therapeutics AG - Common Shares?
The current price of CRISPR Therapeutics AG - Common Shares is 51.83
When was CRISPR Therapeutics AG - Common Shares last traded?
The last trade of CRISPR Therapeutics AG - Common Shares was at 09/15/26 04:00 PM ET
What is the market capitalization of CRISPR Therapeutics AG - Common Shares?
The market capitalization of CRISPR Therapeutics AG - Common Shares is 4.09B
How many shares of CRISPR Therapeutics AG - Common Shares are outstanding?
CRISPR Therapeutics AG - Common Shares has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
